In vivo, TIMER analysis37 indicated that Mi-2β mRNA levels negatively correlated with CCL5, CD74 and CD40 mRNA levels in patients in the TCGA melanoma cohort (p < 0.01) (Supplementary Fig. 4a). The gene discussed is CHD4; the disease is melanoma.